288 related articles for article (PubMed ID: 10997214)
1. Current management of noninvasive (in situ) breast cancer.
Silverstein MJ
Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
[No Abstract] [Full Text] [Related]
2. Noninvasive carcinoma of the breast: the rationale for various treatment options.
Kuske RR
J La State Med Soc; 1994 Apr; 146(4):128-32. PubMed ID: 8006495
[TBL] [Abstract][Full Text] [Related]
3. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
Haase W
Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
[No Abstract] [Full Text] [Related]
4. William Hunter Harridge Lecture: Contemporary management of pre-invasive and early breast cancer.
Bland KI
Am J Surg; 2011 Mar; 201(3):279-89. PubMed ID: 21367364
[No Abstract] [Full Text] [Related]
5. The problem of ductal carcinoma in situ of the breast.
Fentiman IS
Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
[TBL] [Abstract][Full Text] [Related]
6. [Lobular carcinoma in situ as a component of breast cancer points to no contraindication for breast-conserving therapy].
Sautter-Bihl ML
Strahlenther Onkol; 2001 Jan; 177(1):51-2. PubMed ID: 11200114
[No Abstract] [Full Text] [Related]
7. [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].
Noël G; Proudhom MA; Mazeron JJ
Cancer Radiother; 1999; 3(4):342-3. PubMed ID: 10486547
[No Abstract] [Full Text] [Related]
8. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
Gabriel H
AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
[No Abstract] [Full Text] [Related]
9. Therapy of in situ cancer.
Recht A; Connolly JL; Schnitt SJ; Harris JR
Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
[TBL] [Abstract][Full Text] [Related]
10. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
[TBL] [Abstract][Full Text] [Related]
11. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
[No Abstract] [Full Text] [Related]
12. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
[No Abstract] [Full Text] [Related]
13. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome.
Bradley SJ; Weaver DW; Bouwman DL
Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336
[TBL] [Abstract][Full Text] [Related]
14. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
15. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
Fisher B; Costantino J; Redmond C; Fisher E; Margolese R; Dimitrov N; Wolmark N; Wickerham DL; Deutsch M; Ore L
N Engl J Med; 1993 Jun; 328(22):1581-6. PubMed ID: 8292119
[TBL] [Abstract][Full Text] [Related]
16. [Minimal carcinoma of the breast].
Leggeri A; Roseano M; Bortul M; Calligaris L
Ann Ital Chir; 1991; 62(5):427-31. PubMed ID: 1666274
[No Abstract] [Full Text] [Related]
17. In-situ breast cancer: the EORTC consensus meeting.
van Dongen JA; Fentiman IS; Harris JR; Holland R; Peterse JL; Salvadori B; Stewart HJ
Lancet; 1989 Jul; 2(8653):25-7. PubMed ID: 2567800
[No Abstract] [Full Text] [Related]
18. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy.
Moran M; Haffty BG
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):353-8. PubMed ID: 9457821
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
20. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
Fisher ER
CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
